Examining surgery and medications for obstructive sleep apnea
Official title: Endotypic Traits and Obstructive Sleep Apnea Surgery
Run by University of California, Los Angeles · NCT05953610 · Data updated 2026-11-12
This study is testing if soft palate surgery and certain medications can help people with moderate to severe obstructive sleep apnea who can't use a CPAP machine feel better and breathe easier.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 2 sites (Santa Monica, California and 1 other locations) |
| Status | Recruiting |
| Started | January 7, 2024 |
| Main results expected | August 31, 2028 |
| Study ends | August 31, 2028 |
| Registry record updated | July 1, 2026 |
| Trial ID | NCT05953610 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21 and older with moderate to severe obstructive sleep apnea who are intolerant to positive airway pressure therapy.
✕Probably not a fit
Patients with uncontrolled nasal obstruction, significant psychiatric disorders, or other co-existing sleep disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the outcomes of soft palate surgery and the effects of medications like acetazolamide and eszopiclone on patients with moderate to severe obstructive sleep apnea (OSA) who cannot tolerate positive airway pressure. It involves a cohort of 150 participants undergoing drug-induced sleep endoscopy to measure upper airway closing pressure and assess OSA severity before and six months after surgery. The study aims to identify underlying mechanisms of OSA and evaluate treatment efficacy through a randomized crossover design for those who do not achieve resolution of OSA post-surgery.
Why it matters
Potential benefit: If successful, this study could provide new treatment options for patients with obstructive sleep apnea who do not respond to conventional therapies.
How similar studies have gone: Other studies have shown promise in similar approaches, but this specific combination of interventions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria are: 1. age ≥21 years; 2. moderate to severe OSA (obstructive AHI ≥ 15 events/hour); 3. central/mixed apnea index \<5 events/hour; 4. intolerance of positive airway pressure (defined as use \< 2 hours/night at least 5 nights/week); 5. intolerance or poor candidate for oral appliance; 6. participant has provided informed consent for palate surgery as part of their standard of care; 7. tonsil size 0-2+ (without markedly enlarged tonsils that have high surgical success rates); 8. DISE without evidence of complete tongue-related obstruction (reflecting poorer results with isolated palate surgery); 9. medications stable for ≥2 months; 10. body mass index \<35 kg/m2; 11. absence of uncontrolled nasal obstruction; 12. no prior pharyngeal surgery other than tonsillectomy; 13. no neurologic, cardiac or pulmonary disorders; 14. absence of psychiatric disorder except for treated depression or mild anxiety; 15. no co-existing sleep disorder, such as narcolepsy, chronic insomnia, or restless legs syndrome; 16. no use of hypnotics, anxiolytics, stimulants, or sedating antidepressants; 17. no near-miss or prior motor vehicle crash due to sleepiness in past 12 months; and 18. \<3 caffeinated beverages daily. Exclusion criteria are: 1. history of allergic reaction to either of the study drugs; 2. subjects with prior serious allergic reaction (such as Stevens-Johnson syndrome) to sulfonamides; 3. subjects with a history of hypersensitivity to either of the two study drugs; 4. subjects who are on high-dose aspirin therapy due to risk of severe metabolic acidosis; 5. subjects with severe kidney disease or severe liver disease; 6. subjects with a history of electrolyte imbalance or adrenal insufficiency (due to risks related to acetazolamide); 7. subjects on ketoconazole or other strong CYP3A4 inhibitors (these will increase eszopiclone blood levels); 8. pregnancy; and 9. alcohol or substance abuse.
Where it's running
-
UCLA Santa Monica Medical Center
Santa Monica, California, United States Recruiting -
UCLA Westwood
Westwood, Los Angeles, California, United States Not yet recruiting
Study contacts
- Study coordinator: Eric J Kezirian, MD, MPH
- Email: EKezirian@mednet.ucla.edu
- Phone: 32344257904242596559
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
CES-EES score and a wearable ring for diagnosing obstructive sleep apnea
This study tests whether the CES-EES clinical score and the Belun Ring wearable can accurately diagnose obstructive sleep apnea without in-lab polysomnography in adults referred for suspected OSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.